• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

primary immunodeficiency (PI) - Articles and news items

FDA approves Shire’s CUVITRU for the treatment of primary immunodeficiency

Industry news / 20 September 2016 / Niamh Louise Marriott, Digital Content Producer

CUVITRU is a treatment for patients with primary immunodeficiency (PI), a group of more than 300 genetic disorders in which part of the body’s immune system is missing or functions improperly…

 

Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringWATCH NOW
+ +